Clinic
Cesar a Parra MD, PA
Cesar a Parra MD, PA was paid $10.67M by Medicaid between Jan 2018 and Dec 2024, across 63 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 47% of everything it billed.
33Billing provider infoCESAR A PARRA MD, PA
HOUSTON, TX 77055
HOUSTON, TX 77055
33aNPI1275586349assigned 05/18/2006
33bProvider typeClinic/Center
28Total paid$10.67M
24GClaims381,514
24DCodes billed63
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Texas
Rank by total paid#2 of 176
Median peer was paid$26K
This provider vs. median405×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,385 | $42K | |
| 2019 | 1,773 | $50K | |
| 2020 | 24,197 | $612K | |
| 2021 | 90,966 | $2.29M | |
| 2022 | 96,948 | $2.78M | |
| 2023 | 83,562 | $2.51M | |
| 2024incomplete | 82,683 | $2.39M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 47% | 138,763 | 126,627 | $5.00M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.6% | 13,105 | 12,586 | $1.03M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 9.4% | 12,345 | 11,907 | $1.01M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 8.0% | 9,495 | 9,148 | $849K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.3% | 54,119 | 26,948 | $563K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.1% | 7,393 | 7,077 | $547K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.7% | 5,124 | 4,978 | $286K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.9% | 15,090 | 14,493 | $206K |
| 99381 | 1.8% | 2,864 | 2,762 | $196K | |
| 99000 | 1.7% | 18,113 | 17,616 | $179K | |
| 99382 | 1.1% | 1,295 | 1,267 | $118K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 9,507 | 9,128 | $101K |
51 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 6,942 | $97K |
| 99383 | <1% | 943 | $84K | |
| S8301 | Infection control supplies, not otherwise specified | <1% | 6,114 | $75K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 731 | $61K |
| 90461 | <1% | 7,280 | $46K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,697 | $42K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 950 | $36K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,911 | $29K |
| 99384 | <1% | 238 | $24K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 455 | $23K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,960 | $23K |
| 0071A | <1% | 529 | $17K | |
| 0072A | <1% | 281 | $12K | |
| 97169 | <1% | 476 | $9K | |
| 81002 | <1% | 2,383 | $7K | |
| 87807 | <1% | 465 | $5K | |
| 86328 | <1% | 57 | $2K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 13 | $538.95 |
| 93000 | <1% | 25 | $306.76 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 27 | $172.62 |
| 90733 | <1% | 623 | $90.40 | |
| 96160 | <1% | 3,595 | $20.98 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 318 | $4.84 |
| 90697 | <1% | 2,439 | $1.10 | |
| 90686 | <1% | 10,523 | $0.91 | |
| 90620 | <1% | 2,344 | $0.47 | |
| 90715 | <1% | 2,047 | $0.36 | |
| 90671 | <1% | 2,306 | $0.11 | |
| 91307 | <1% | 879 | $0.06 | |
| 90670 | <1% | 4,605 | $0.06 | |
| 90734 | <1% | 2,456 | $0.06 | |
| 90744 | <1% | 1,141 | $0.05 | |
| 90651 | <1% | 1,869 | $0.04 | |
| 90696 | <1% | 1,772 | $0.03 | |
| 90710 | <1% | 1,845 | $0.03 | |
| 90680 | <1% | 4,373 | $0.01 | |
| 90633 | <1% | 4,208 | $0.01 | |
| 90716 | 0% | 2,014 | $0.00 | |
| 90698 | 0% | 2,277 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 447 | $0.00 |
| 90647 | 0% | 409 | $0.00 | |
| 90723 | 0% | 146 | $0.00 | |
| 91305 | 0% | 42 | $0.00 | |
| 90677 | 0% | 38 | $0.00 | |
| 90700 | 0% | 1,756 | $0.00 | |
| 90649 | 0% | 1,248 | $0.00 | |
| 90707 | 0% | 2,024 | $0.00 | |
| 90648 | 0% | 988 | $0.00 | |
| 90681 | 0% | 29 | $0.00 | |
| 90658 | 0% | 51 | $0.00 | |
| 91308 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPARRA, CESAR (PEDIATRICIAN)